delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
前列腺癌中的 δ-连环蛋白和细胞间粘附
基本信息
- 批准号:7035153
- 负责人:
- 金额:$ 18.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Prostate cancer (CaP) is the most common malignancy in men in US and the second leading cause of cancer mortality. To reduce the significant morbidity and mortality, new strategies for CaP prevention and treatment depend on the determination of specific molecular mechanisms involved in this disease. ?-Catenin is a unique armadillo (ARM) domain-containing protein in that it is neural specific and primarily expresses in the brain. However, ?-catenin expression increases in prostatic adenocarcinomas, redistributes E-cadherin/p120ctn from the cell-cell junction, and promotes CaP cell growth and invasion. To investigate this largely unexplored area of neuronal catenin gene expression in peripheral tissues of cancers, the overall goal of this project is to test the hypothesis that ?-catenin promotes CaP formation and progression by interacting with multiple cellular machineries, including cell-cell and cell-matrix adhesion, cell growth/survival, and invasion. There are three specific aims in this proposal. Specific Aim 1 will determine how ?-catenin promotes cell growth/survival and motility in response to the hepatocyte growth factor and/or androgen using CWR22 tumor xenografts and their derived cell lines. We will broadly screen and profile the ?-catenin induced alteration of signaling molecules by array technology. These studies will identify cancer specific pathways that ?-catenin is involved in and will investigate their interactions with ?-catenin using protein co-immunoprecipitation and yeast two-hybrid analyses. Specific Aim 2 will determine how ?-catenin interacts with Rho family small GTPases to disrupt adherens junction and promote CaP cell growth/survival and invasion. We will first identify the ?-catenin sequence responsible for this action. Then, the analyses of ?-catenin RNAi or its mutants that are defective in Rac-1 or E-cadherin binding will determine the interactions between GTP-Rac-1/IQGAP-1 and E-cadherin/p120ctn pathways to reveal possible differential modulations on cell-cell adhesion and cell growth/survival and invasion. We will also determine the cytoplasmic accumulation and nuclear signaling of ?-catenin that is released from E-cadherin complexes by IQGAP-1. Specific Aim 3 will apply Y311, a unique (dePhospho-specific) monoclonal antibody, and site-directed mutagenesis to determine how ?-catenin modifications occur and what are their roles in CaP. We will also investigate ?-catenin proteolytic fragments and their potentials as DNA binding proteins and nuclear signaling for gene expression. Finally, we will generate transgenic mice displaying prostate tissue specific ?-catenin expression to approach these questions at the animal level. These studies will place ?-catenin into the broad context of growth factor and kinase signaling machineries relevant to CaP. Understanding the posttranslational modifications that control ?-catenin functions will unravel mechanisms by which ?-catenin modulates gene expression and promotes CaP in vivo.
描述(申请人提供):前列腺癌(CAP)是美国男性最常见的恶性肿瘤,是癌症死亡的第二大原因。为了减少严重的发病率和死亡率,预防和治疗CAP的新策略取决于对这种疾病所涉及的特定分子机制的确定。?-连环蛋白是一种独特的含有手臂结构域的蛋白质,因为它是神经特异性的,主要在大脑中表达。然而,β-catenin在前列腺癌中的表达增加,使E-cadherin/p120ctn从细胞-细胞连接处重新分布,并促进帽细胞的生长和侵袭。为了研究肿瘤外周组织中神经元连环蛋白基因表达的这一未知区域,本项目的总体目标是检验这一假说,即?-连环蛋白通过与多种细胞机制相互作用促进帽子的形成和进展,包括细胞-细胞和细胞-基质黏附、细胞生长/存活和侵袭。这项提议有三个具体目标。具体目标1将通过使用CWR22肿瘤移植瘤及其衍生细胞系来确定?-连环蛋白如何在肝细胞生长因子和/或雄激素的反应中促进细胞的生长/存活和运动。我们将利用阵列技术对β-连环蛋白诱导的信号分子改变进行广泛的筛选和分析。这些研究将确定?-catenin参与的癌症特定途径,并将使用蛋白质免疫共沉淀和酵母双杂交分析来研究它们与?-catenin的相互作用。特异性目标2将确定?-catenin如何与Rho家族小GTP酶相互作用,破坏粘着连接,促进帽细胞的生长/存活和侵袭。我们将首先确定负责这一作用的?-连环蛋白序列。然后,对Rac-1或E-cadherin结合缺陷的β-catenin RNAi及其突变体的分析将确定GTP-Rac-1/IQGAP-1与E-cadherin/p120ctn通路之间的相互作用,以揭示可能对细胞间黏附和细胞生长/存活和侵袭的差异调控。我们还将测定IQGAP-1从E-钙粘附素复合体释放出来的β-连环蛋白的胞质积累和核信号转导。特殊目标3将应用Y311,一种独特的(脱磷特异的)单抗,和定点突变来确定?-连环蛋白修饰是如何发生的,以及它们在CAP中的作用。我们还将研究β-连环蛋白的蛋白分解片段及其作为DNA结合蛋白和核信号表达基因的潜力。最后,我们将产生显示前列腺组织特异性连环蛋白表达的转基因小鼠,以在动物水平上探讨这些问题。这些研究将把β-连环蛋白放入与CAP相关的生长因子和激酶信号机制的广泛背景中。了解控制?-catenin功能的翻译后修饰将揭开?-catenin在体内调节基因表达和促进CAP的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
QUN LU其他文献
QUN LU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('QUN LU', 18)}}的其他基金
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases
稳态重置作为缓慢进展疾病的新治疗范式
- 批准号:
10273546 - 财政年份:2021
- 资助金额:
$ 18.95万 - 项目类别:
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases
稳态重置作为缓慢进展疾病的新治疗范式
- 批准号:
10689335 - 财政年份:2021
- 资助金额:
$ 18.95万 - 项目类别:
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases
稳态重置作为缓慢进展疾病的新治疗范式
- 批准号:
10796004 - 财政年份:2021
- 资助金额:
$ 18.95万 - 项目类别:
Homeostatic Reset as a New Therapeutic Paradigm for Slow Progression Diseases
稳态重置作为缓慢进展疾病的新治疗范式
- 批准号:
10488273 - 财政年份:2021
- 资助金额:
$ 18.95万 - 项目类别:
Rho GTPases and Neuroprotection Model in Cancer Therapy
Rho GTPases 和癌症治疗中的神经保护模型
- 批准号:
8232481 - 财政年份:2012
- 资助金额:
$ 18.95万 - 项目类别:
Rho GTPases and Neuroprotection Model in Cancer Therapy
Rho GTPases 和癌症治疗中的神经保护模型
- 批准号:
8769217 - 财政年份:2012
- 资助金额:
$ 18.95万 - 项目类别:
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
前列腺癌中的 δ-连环蛋白和细胞间粘附
- 批准号:
7186628 - 财政年份:2006
- 资助金额:
$ 18.95万 - 项目类别:
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
前列腺癌中的 δ-连环蛋白和细胞间粘附
- 批准号:
8068992 - 财政年份:2006
- 资助金额:
$ 18.95万 - 项目类别:
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
前列腺癌中的 δ-连环蛋白和细胞间粘附
- 批准号:
7554661 - 财政年份:2006
- 资助金额:
$ 18.95万 - 项目类别:
delta-Catenin and Cell-Cell Adhesion in Prostate Cancer
前列腺癌中的 δ-连环蛋白和细胞间粘附
- 批准号:
7345429 - 财政年份:2006
- 资助金额:
$ 18.95万 - 项目类别:
相似国自然基金
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
- 批准号:TGY24H080011
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Continuing Grant
Probing the mechano-biology of cell-cell adhesion in a novel single cell assay
在新型单细胞测定中探讨细胞间粘附的力学生物学
- 批准号:
EP/Y002245/1 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Research Grant
Coating the cell surface with adhesive polymers: a strategy to enhance cell adhesion
用粘附聚合物涂覆细胞表面:增强细胞粘附的策略
- 批准号:
EP/X037622/1 - 财政年份:2024
- 资助金额:
$ 18.95万 - 项目类别:
Research Grant
Role of the Glycocalyx and Spike-Like Proteins in Virus-Cell Adhesion
糖萼和刺突状蛋白在病毒-细胞粘附中的作用
- 批准号:
2226779 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Standard Grant
In vivo and ex vivo lessons from somatic adrenal mutations in cell adhesion molecule 1 for physiological and pathological production of aldosterone
细胞粘附分子 1 体细胞肾上腺突变对醛固酮生理和病理产生的体内和离体教训
- 批准号:
MR/X018970/1 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Fellowship
Study of dynamic three-dimensional structure of pathogenic bacterial pili and its host cell adhesion mechanism by X-ray structure and cryo-EM
X射线结构和冷冻电镜研究病原菌菌毛动态三维结构及其宿主细胞粘附机制
- 批准号:
23K04944 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism for the regulation of neuroblast chain migration by the cell adhesion molecule.
细胞粘附分子调节神经母细胞链迁移的分子机制。
- 批准号:
23K05770 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Canonical Roles for Cell-Adhesion Molecules in Presynaptic Assembly
细胞粘附分子在突触前组装中的非典型作用
- 批准号:
10751904 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Cell-adhesion mechanisms of inhibitory synapse specificity and their dysfunction in neuropsychiatric disorders
抑制性突触特异性的细胞粘附机制及其在神经精神疾病中的功能障碍
- 批准号:
488087 - 财政年份:2023
- 资助金额:
$ 18.95万 - 项目类别:
Operating Grants














{{item.name}}会员




